PaxMedica, Financial Statements From 2010 to 2025
| PXMDDelisted Stock | USD 0.86 0.18 17.31% |
Check PaxMedica, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PaxMedica, Common's main balance sheet or income statement drivers, such as , as well as many indicators such as . PaxMedica, financial statements analysis is a perfect complement when working with PaxMedica, Common Valuation or Volatility modules.
PaxMedica, |
PaxMedica, Common Stock Company Return On Equity Analysis
PaxMedica, Common's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PaxMedica, Common Return On Equity | -10.47 |
Most of PaxMedica, Common's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PaxMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PaxMedica, Common Stock has a Return On Equity of -10.4696. This is 56.32% lower than that of the Biotechnology sector and 71.28% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
PaxMedica, Common Stock Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PaxMedica, Common's current stock value. Our valuation model uses many indicators to compare PaxMedica, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PaxMedica, Common competition to find correlations between indicators driving PaxMedica, Common's intrinsic value. More Info.PaxMedica, Common Stock is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PaxMedica, Common's earnings, one of the primary drivers of an investment's value.About PaxMedica, Common Financial Statements
PaxMedica, Common stakeholders use historical fundamental indicators, such as PaxMedica, Common's revenue or net income, to determine how well the company is positioned to perform in the future. Although PaxMedica, Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in PaxMedica, Common's assets and liabilities are reflected in the revenues and expenses on PaxMedica, Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PaxMedica, Common Stock. Please read more on our technical analysis and fundamental analysis pages.
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC. Paxmedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |